The abrupt passing of Bollywood star Shefali Jariwala, a longstanding user of anti-aging treatments, has reignited apprehensions in India regarding instant beauty solutions and a growing number of cardiac incidents among seemingly fit young adults.
Jariwala, aged 42, passed away last week at her residence in Mumbai following a suspected major cardiac arrest. According to police reports, she had been utilizing anti-aging injectables for several years in conjunction with standard medications.
Authorities found two packages of anti-aging and skin renewal tablets containing glutathione and vitamins at her home. Glutathione is not sanctioned for use in India, and she was said to have undergone multiple treatments, including intravenous infusions.
The Central Drugs Standard Control Organisation oversees pharmaceuticals in India, ensuring drug and cosmetic safety and quality, and has implemented measures to curb instant beauty therapies in line with government directives.
While the final autopsy report is still awaited, initial findings suggest a sudden and drastic reduction in blood pressure – a frequent cause of cardiac arrest.
Jariwala’s unforeseen demise has astonished fans and health professionals alike, leading to renewed examination of unregulated treatments and the lifestyle choices of India’s health-conscious youth.